Baxter International, Inc.

762 articles with Baxter International, Inc.

• Baxter to Present at the Bank of America Merrill Lynch Health Care Conference 2019

  4/16/2019

  Baxter International Inc., a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019.

• Baxter Unveils the Latest Evolution of Floseal at AORN Meeting

  4/9/2019

  Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo.

• Baxter to Host Webcast of Annual Meeting of Stockholders

  4/4/2019

  Baxter International Inc., a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.

• Baxter Highlights Advancements in Clinical Nutrition at ASPEN Conference

  3/26/2019

  Reinforces the company’s efforts to innovate nutrition formulations and delivery mechanisms to meet the needs of patients

• Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

  3/19/2019

  Baxter International Inc. announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).

• Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors

  3/7/2019

  Baxter International Inc., a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time.

• Baxter Announces U.S. FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide

  3/6/2019

  First and only premixed presentation of eptifibatide available in a flexible container Eptifibatide is the latest addition to Baxter’s broad line of ready-to-use medications intended to help enhance patient safety and support pharmacy efficiency

• Baxter Honored as a 2019 “Top Company for Executive Women” by the National Association for Female Executives

  3/5/2019

  From board representation to pay equity, company promotes an ongoing commitment to advance women in leadership

• Baxter Declares Quarterly Dividend payable on April 1, 2019

  2/19/2019

  Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock.

• Baxter to Present at the Barclays Global Healthcare Conference

  2/13/2019

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019.

• Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU

  2/11/2019

  NantHealth has validated successful DeviceConX™ integration with Baxter’s Prismaflex system, used to treat critically-ill patients in the ICU

• Baxter Reports 2018 Fourth-Quarter and Full-Year Results

  1/31/2019

  Fourth-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 5 percent on an operational basis

• Baxter to Present at the 8th Annual SVB Leerink Global Healthcare Conference

  1/29/2019

  Baxter International, Inc., a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019.

• Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management

  1/17/2019

  Sharesource remote patient management – now available in 40 countries – is evolving peritoneal dialysis practice management

• Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System

  1/7/2019

  First patients have been enrolled in the clinical trial for next generation dialysis technology

• Baxter Signs Open Data Pledge to Improve Patient Safety

  1/2/2019

  The Patient Safety Movement Foundation (PSMF) announced today that Baxter International Inc. (NYSE:BAX), a global medical products company, has signed the PSMF’s Open Data Pledge as the 89th company to demonstrate the importance of data sharing to improving patient safety.

• Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures

  12/18/2018

  New applicator provides surgeons with greater control during ENT surgeries to help foster improved outcomes for patients

• Baxter Appoints Patricia Morrison and Amy Wendell to Its Board

  12/6/2018

  Addition of industry veterans reflects ongoing board refreshment efforts and commitment to further diversification

• Baxter Supports New EFCNI Standards in Newborn Care in Raising Awareness of Risks from Malnutrition

  12/6/2018

  Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, is collaborating with the European Foundation for the Care of Newborn Infants (EFCNI) to raise awareness for the new EFCNI standards that address the disparities in newborn care in Europe

• Baxter to Present at the 37th Annual J.P. Morgan Healthcare Conference

  12/4/2018

  Baxter International Inc. will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 7, 2019 at 10 a.m. Pacific Time.